[HTML][HTML] Overcoming Limited Access to Virus Infection Rapid Testing: Development of a Lateral Flow Test for SARS-CoV-2 with Locally Available Resources

ES Peri Ibáñez, A Mazzeo, C Silva, MJ Juncos… - Biosensors, 2024 - mdpi.com
The COVID-19 pandemic highlighted testing inequities in developing countries. Lack of
lateral flow test (LFT) manufacturing capacity was a major COVID-19 response bottleneck in …

Equine anti-SARS-CoV-2 serum (ECIG) binds to mutated RBDs and N proteins of variants of concern and inhibits the binding of RBDs to ACE-2 receptor

SA Andrade, JV Batalha-Carvalho, R Curi… - Frontiers in …, 2022 - frontiersin.org
The COVID-19 pandemic caused by the severe acute syndrome virus 2 (SARS-CoV-2) has
been around since November 2019. As of early June 2022, more than 527 million cases …